Jeraj, Robert

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 2,834

Federated learning enables big data for rare cancer boundary detection

Pati, S., Baid, U., Edwards, B., Sheller, M., Wang, S.-H., Reina, G. A., Foley, P., Gruzdev, A., Karkada, D., Davatzikos, C., et al. (2022) · Nature Communications

Privacy-Preserving Technologies in DataBrain Tumor Detection and Classification

Cited by 394

Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response

Vanderhoek, M., Perlman, S. B., & Jeraj, R. (2012) · Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical Imaging

Cited by 188

Interpretation and visualization techniques for deep learning models in medical imaging

Huff, D. T., Weisman, A. J., & Jeraj, R. (2021) · Physics in Medicine & Biology

Explainable Artificial Intelligence (XAI)Artificial Intelligence in Healthcare and Education

Cited by 172

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., et al. (2013) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 70

Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response

Vanderhoek, M., Perlman, S. B., & Jeraj, R. (2013) · Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical Imaging

Cited by 47